A study will be conducted to demonstrate that DRISTi will correctly diagnose Diabetic Retinopathy (e.g., mtmDR, PDR, DME) in eyes of patients with diabetes. Participants who have been diagnosed with diabetes mellitus and meet the other inclusion/exclusion criteria will be invited to participate and will consent to have ophthalmic images taken. These images will be analyzed by DRISTi AI software and evaluated by an ophthalmic reading center. The results will be compared, and a statistical analysis will be completed to ensure statistical significance in the outcomes thus proving DRISTi is an effective DR diagnosis tool.
Study Type
OBSERVATIONAL
Enrollment
900
The image is graded by a fully automated AI device
New Century Ophthalmology - Oxford
Oxford, North Carolina, United States
RECRUITINGNew Century Ophthalmology - Raleigh
Raleigh, North Carolina, United States
RECRUITINGAccuracy of AI Grade
AI generated image grades are directly compared to a Human generated image grade
Time frame: From time of arrival to completion of diagnostic tests, up to 8 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.